Association of CDX2 expression with clinical, pathologic, and molecular features in MSI-H colorectal cancer

被引：0
|
作者：
Gonzalez, Cyndi
Neyaz, Azfar
Layding, Caroline Jane
Ferrell, Morgan
Giza, Richard
Cheng, Svea
Syed, Masood Pasha
Magge, Tara
Saeed, Anwaar
Tatsuoka, Curtis
Singhi, Aatur D.
Sahin, Ibrahim Halil Halil
机构：
[1] Univ Pittsburgh Med Ctr UPMC, Pittsburgh, PA USA
[2] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15583
引用
收藏
页数：1
相关论文
共 50 条
  • [41] The microenvironment controls CDX2 homeobox gene expression in colorectal cancer cells
    Benahmed, Fairouz
    Gross, Isabelle
    Guenot, Dominique
    Jehan, Frederic
    Martin, Elisabeth
    Domon-Dell, Claire
    Brabletz, Thomas
    Kedinger, Michele
    Freund, Jean-Noel
    Duluc, Isabelle
    AMERICAN JOURNAL OF PATHOLOGY, 2007, 170 (02): : 733 - 744
  • [42] CDX2 expression in gastric carcinomas: Association with mucin expression pattern, clinicopathological features and prognosis
    Silva, Edaise
    Begnami, Maria
    Sato-Kuwabara, Yukie
    Paiva, Geisa
    Montagnini, Andre
    Soares, Fernando
    CANCER RESEARCH, 2009, 69
  • [43] Homeodomain protein CDX2 regulates COX-2 expression in colorectal cancer
    Kim, SP
    Park, JW
    Lee, SH
    Lim, JH
    Jang, BC
    Lee, SH
    Jang, IH
    Freund, JN
    Suh, SI
    Mun, KC
    Song, DK
    Ha, EM
    Lee, WJ
    Kwon, TK
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 315 (01) : 93 - 99
  • [44] The prognostic potential of CDX2 in colorectal cancer: Harmonizing biology and clinical practice
    Badia-Ramentol, Jordi
    Gimeno-Valiente, Francisco
    Durendez, Elena
    Martinez-Ciarpaglini, Carolina
    Linares, Jenniffer
    Iglesias, Mar
    Cervantes, Andres
    Calon, Alexandre
    Tarazona, Noelia
    CANCER TREATMENT REVIEWS, 2023, 121
  • [45] Methylation of CDX2 as a Predictor in Poor Clinical Outcome of Patients with Colorectal Cancer
    Jiang, Guozhong
    Luo, Chenglin
    Sun, Miaomiao
    Zhao, Zhihua
    Li, Wencai
    Chen, Kuisheng
    Fan, Tianli
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2016, 20 (11) : 710 - 714
  • [46] Expression of CDX2 in metastatic prostate cancer
    Guerrieri, C.
    Jobbagy, Z.
    Hudacko, R.
    PATHOLOGICA, 2019, 111 (03) : 105 - 107
  • [47] Clinicopathological Features of Colorectal Carcinoma in Ukrainian Patients with MSI-H and MSS Status
    Shapochka, D.
    Vykhrieva, M.
    Selezniov, O.
    Turkina, A.
    Shapochka, T.
    Sulaieva, O.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (03): : S30 - S30
  • [48] The Prognostic and Predictive Utility of CDX2 in Colorectal Cancer
    Chan, Wei Yen
    Chua, Wei
    Wilkinson, Kate
    Epitakaduwa, Chandika
    Mandaliya, Hiren
    Descallar, Joseph
    Roberts, Tara Laurine
    Becker, Therese Maria
    Ng, Weng
    Lee, Cheok Soon
    Lim, Stephanie Hui-Su
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (16)
  • [49] CDX2 immunohistochemistry as a prognostic biomarker for colorectal cancer
    Fatimilehin, A.
    Mikropoulos, C.
    Summers, J.
    Rajakumar, L.
    Hill, M.
    ANNALS OF ONCOLOGY, 2018, 29
  • [50] Duration of immunotherapy in dMMR/MSI-H metastatic colorectal cancer patients
    Margalit, Ofer
    Stemmer, Amos
    Chapin, William J.
    Shacham-Shmueli, Einat
    Kopetz, Scott
    Andre, Thierry
    Overman, Michael J.
    Pietrantonio, Filippo
    Boursi, Ben
    EUROPEAN JOURNAL OF CANCER, 2024, 212
12345